McElhaugh Michael J.
- SEC CIK
- 0001635326
No open-market purchases or sales filed in the past year.
Current role at each company
- ABUS Arbutus Biopharma CorpInterim President & CEOas of Feb 19, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists McElhaugh Michael J. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2025 (view filing) | Feb 4 | 1 day | McElhaugh Michael J.Interim President & CEO | SSale | −23.8K | $3.28 | −$78.0K | −1.6%1.48M after | 10b5-1 |
| Feb 5, 2024 (view filing) | Feb 2 | 3 days | McElhaugh Michael J.Interim President & CEO | SSale | −10.2K | $2.31 | −$23.5K | −0.7%1.50M after | 10b5-1 |